Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Make your choice for a definitive Christmas place to get-away! - 2An eye for an eye: People agree about the values of body parts across cultures and eras
- 3NASA begins fueling rocket to launch astronauts on the first lunar trip in half a century
- 4Inside The Design-Forward Wellness Hotel Marking A New Chapter In Medellín
- 5One lightly wounded after Iranian missile barrage targets northern Israel
- How a niche Catholic approach to infertility treatment became a new talking point for MAHA conservatives
- Volcanic eruption led to the Black Death, new research suggests
- Book excerpt: "Enough" by Dr. Ania Jastreboff and Oprah Winfrey
- Find the Standards of Viable Nurturing: Supporting Blissful and Strong Kids
- Russia Establishing Long-Range Drone Bases In Belarus, Warns Ukraine
- Israel Police arrest twenty-one as anti-war protests grow despite broad support for Iran war
- Dick Van Dyke shares his secrets to longevity as he turns 100
- Germany's Bundestag extends two armed forces missions abroad
- WHO suspends Gaza medical evacuations after contractor killed by Israeli troops
